A consistent approach to NHS policies on surgical innovation is urgently needed, a landmark study by University of Bristol researchers has shown.
An increase in the number of non-COVID-19 respiratory infections should be expected this winter, say scientists.
How well patients recover after a hip fracture varies enormously between NHS hospitals in England and Wales and in some hospitals one in ten patients died within a month of their fracture, a new study has found.
For lesbian, gay, bisexual, transgender and queer (LGBTQ+) people, the COVID-19 pandemic has brought a lot of inequities faced by their community to the fore, including the precarious state of their mental health.
A team of researchers at Weill Cornell Medicine in New York City has unraveled a decades-long mystery blanketing the purpose of some chemical modifications in messenger RNAs (mRNAs).
The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer’s Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against the BA.2 variant of SARS-CoV-2, the virus that causes COVID-19.
Sepsis, the body’s overreaction to an infection, affects more than 1.5 million people and kills at least 270,000 every year in the U.S. alone. The standard treatment of antibiotics and fluids is not effective for many patients, and those who survive face a higher risk of death.
Lab-grown human heart cells provide a powerful tool to understand and potentially treat heart disease. However, the methods to produce human heart cells from pluripotent stem cells are not optimal.
Two of the most common genetic changes that cause cells to become cancerous, which were previously thought to be separate and regulated by different cellular signals, are working in concert, according to new research from the University of Wisconsin–Madison.
The bacterium Staphylococcus aureus has long been known to cause infections in humans, ranging from mild skin infections to pneumonia to more serious infections of the heart.
New research from the University of Virginia School of Medicine has found that the use of common antidepressants known as selective serotonin reuptake inhibitors (SSRIs) during pregnancy can interact with inflammation, increasing the risk of neurodevelopmental disorders.
Like the hardiest weed, glioblastoma almost always springs back — usually within months after a patient’s initial brain tumor is surgically removed. That is why survival rates for this cancer are just 25 percent at one year and plummet to 5 percent by the five-year mark.
A team led by University of Wisconsin–Madison Stem Cell & Regenerative Medicine Center researcher Wan-Ju Li offers an improved way to create a particularly valuable type of stem cell in pigs – a cell that could speed the way to treatments that restore damaged tissues for conditions from osteoarthritis to heart disease in human patients.
University of Wisconsin–Madison researchers have developed a new method for targeting tumors with cancer drugs by exploiting the clotting propensity of blood platelets.
A bone marrow transplant can be a lifesaving treatment for people with relapsed blood cancers, but a potentially lethal complication known as graft-versus-host disease put limitations on this procedure.
A groundbreaking discovery by the University of Virginia School of Medicine has challenged a long-held belief in drug development that the drug transporter in blood known as albumin mimics the behavior of human blood in lab models.
Men at the highest risk for prostate cancer could be fast-tracked for investigation if their genetic risk was considered in general practice, new research has concluded.
Blood pressure should be measured in both arms and the higher reading should be adopted to improve hypertension diagnosis and management, according to a new study.
In a new paper detailing findings from North Carolina State University’s GenX Exposure Study, researchers found that elevated levels of per- and polyfluoroalkyl substances (PFAS) were associated with higher total cholesterol and non-HDL cholesterol in participants’ blood.
A COVID-19 booster shot increases durability of antibody response, according to new research from the University of Virginia School of Medicine, which has shed light on the benefits of a booster.